We are live on
!
Find out more
Mackenzie Financial Portfolio holdings
AUM
$83.3B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+15.19%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$46.3B
AUM Growth
+$6.05B
(+15%)
Cap. Flow
+$625M
Cap. Flow
% of AUM
1.35%
Top 10 Holdings %
Top 10 Hldgs %
20.02%
Holding
1,125
New
139
Increased
505
Reduced
364
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$186M |
| 2 |
Alcon
ALC
|
+$163M |
| 3 |
Akamai
AKAM
|
+$157M |
| 4 |
AbbVie
ABBV
|
+$120M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$273M |
| 2 |
FirstService
FSV
|
+$210M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$179M |
| 4 |
Synopsys
SNPS
|
+$137M |
| 5 |
Home Depot
HD
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.92% |
| 2 | Technology | 16.88% |
| 3 | Industrials | 13.41% |
| 4 | Healthcare | 10.72% |
| 5 | Consumer Discretionary | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
601
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.02M | ﹤0.01% |
27,592
+9,635
| +54% | +$716K |
|
602
Twilio
TWLO
$30.1B
| $2.01M | ﹤0.01% |
5,945
-1,902
| -24% | -$594K |
|
|
SA
603
Seabridge Gold
SA
$2.81B
| $2M | ﹤0.01% |
95,570
-4,528
| -5% | -$87.6K |
|
604
Evercore
EVR
$12.1B
| $2M | ﹤0.01% |
18,241
+2,447
| +15% | +$218K |
|
605
Avery Dennison
AVY
$13B
| $1.99M | ﹤0.01% |
12,854
+10,970
| +582% | +$1.59M |
|
606
Marriott International
MAR
$91.9B
| $1.99M | ﹤0.01% |
15,056
+804
| +6% | +$91.8K |
|
|
XLNX
607
DELISTED
Xilinx Inc
XLNX
| $1.98M | ﹤0.01% |
13,950
-1,376,033
| -99% | -$179M |
|
|
MGP
608
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $1.98M | ﹤0.01% |
63,096
+27,302
| +76% | +$814K |
|
|
ALXN
609
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.97M | ﹤0.01% |
12,614
-6,680
| -35% | -$858K |
|
610
West Pharmaceutical
WST
$24.4B
| $1.97M | ﹤0.01% |
6,954
-4,170
| -37% | -$1.17M |
|
611
Regal Rexnord
RRX
$13.9B
| $1.96M | ﹤0.01% |
15,977
+957
| +6% | +$106K |
|
612
Eversource Energy
ES
$26.9B
| $1.96M | ﹤0.01% |
22,638
-15,216
| -40% | -$1.35M |
|
|
VMW
613
DELISTED
VMware, Inc
VMW
| $1.95M | ﹤0.01% |
13,907
-10,720
| -44% | -$1.54M |
|
614
Atkore
ATKR
$3.16B
| $1.94M | ﹤0.01% |
47,137
-3,267
| -6% | -$103K |
|
615
Teradyne
TER
$56.5B
| $1.92M | ﹤0.01% |
16,023
+1,551
| +11% | +$158K |
|
616
Kraft Heinz
KHC
$31B
| $1.92M | ﹤0.01% |
55,401
-11,519
| -17% | -$374K |
|
|
PLG
617
Platinum Group Metals
PLG
$164M
| $1.9M | ﹤0.01% |
413,500
-9,900
| -2% | -$28.5K |
|
618
Cintas
CTAS
$81.8B
| $1.88M | ﹤0.01% |
21,252
+14,292
| +205% | +$1.24M |
|
|
FINV
619
FinVolution Group
FINV
$1.16B
| $1.86M | ﹤0.01% |
+696,801
| New | +$1.49M |
|
620
Etsy
ETSY
$7.89B
| $1.85M | ﹤0.01% |
10,395
+3,323
| +47% | +$500K |
|
621
Truist Financial
TFC
$62.7B
| $1.85M | ﹤0.01% |
38,563
+4,592
| +14% | +$208K |
|
622
Carrier Global
CARR
$51.6B
| $1.82M | ﹤0.01% |
48,243
+29,218
| +154% | +$1.06M |
|
623
Monster Beverage
MNST
$90.7B
| $1.8M | ﹤0.01% |
38,908
-7,390
| -16% | -$311K |
|
624
Bio-Rad Laboratories Class A
BIO
$8.9B
| $1.79M | ﹤0.01% |
3,065
-1,020
| -25% | -$581K |
|
625
OneMain Financial
OMF
$7.42B
| $1.76M | ﹤0.01% |
+36,616
| New | +$1.45M |
|
Similar funds
Mackenzie Financial's Q4 2020 Portfolio in Review
As of Q4 2020, Mackenzie Financial held 1,125 positions worth $46.3B, up 15% from $40.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Mackenzie Financial's Q4 2020 filing shows 139 new, 505 increased, 364 reduced and 91 closed positions. Its largest new stake was HealthEquity: 1,012,307 shares worth $70.6M. The largest sale was Baxter International, an estimated $273M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Mackenzie Financial's largest Q4 2020 buy was HealthEquity: 1,012,307 shares worth $70.6M.
- Mackenzie Financial added most to Amphenol in Q4 2020, an estimated $186M increase.
- Mackenzie Financial's biggest Q4 2020 reduction was Baxter International, cutting an estimated $273M.
- Mackenzie Financial fully exited Vail Resorts in Q4 2020, selling an estimated $85M.
- Mackenzie Financial's ten largest holdings make up 20% of its $46.3B portfolio in Q4 2020.
- Mackenzie Financial opened 139 new positions and closed 91 in Q4 2020.
- Mackenzie Financial's portfolio value rose 15% quarter-over-quarter to $46.3B.
Based on Mackenzie Financial's 13F filing for Q4 2020, filed 10 Feb 2021.